Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

57 та иш

Иш: Modeling of hydrophobic tetrapeptides as a competitive inhibitor for HMG-CoA reductase

  1. The Natural Products as Hydroxymethylglutaryl-Coa Reductase Inhibitors

    Hayrettin Ozan Gülcan, Serkan Yiğitkan, İlkay Erdoğan Orhan

    Мақола20184 иқтибос
    ABI

  2. Inhibitor design for <scp>3‐hydroxy‐3‐methyl‐glutaryl‐CoA</scp> reductase enzyme; molecular docking and determination of molecular and electronic properties of ligands by density functional theory method

    Selami Ercan, Ercan Çınar, Cihat Özaydın +2

    Мақола20204 иқтибос
    ABI

  3. In vitro and in silico studies of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitory activity of the cowpea Gln-Asp-Phe peptide

    Mariana Silva, Caio Souza, Biane Oliveira Philadelpho +7

    Мақола20184 иқтибос
    ABI

  4. IAF, QGF, and QDF Peptides Exhibit Cholesterol-Lowering Activity through a Statin-like HMG-CoA Reductase Regulation Mechanism: In Silico and In Vitro Approach

    Mariana Silva, Biane Oliveira Philadelpho, Johnnie Elton Machado dos Santos +9

    Мақола20214 иқтибос
    ABI

  5. Risk of incident diabetes among patients treated with statins: population based study

    A. A. Carter, Tara Gomes, Ximena Camacho +3

    Мақола20133 иқтибос
    ABI

  6. Peptides from cowpea present antioxidant activity, inhibit cholesterol synthesis and its solubilisation into micelles

    Marcelo Rodrigues Marques, Rosana Aparecida Manólio Soares Freitas, Amanda Caroline Corrêa Carlos +3

    Мақола20143 иқтибос
    ABI

  7. IAVPGEVA, IAVPTGVA, and LPYP, three peptides from soy glycinin, modulate cholesterol metabolism in HepG2 cells through the activation of the LDLR-SREBP2 pathway

    Carmen Lammi, Chiara Zanoni, Anna Arnoldi

    Мақола20153 иқтибос
    ABI

  8. Statin use and risk of diabetes mellitus in postmenopausal women

    Niki Katsiki, Maciej Banach

    Мақола20123 иқтибос
    ABI

  9. Lupin protein exerts cholesterol-lowering effects targeting PCSK9: From clinical evidences to elucidation of the in vitro molecular mechanism using HepG2 cells

    Carmen Lammi, Chiara Zanoni, Laura Calabresi +1

    Мақола20163 иқтибос
    ABI

  10. Hypocholesterolemic effect of sericin-derived oligopeptides in high-cholesterol fed rats

    Phakhamon Lapphanichayakool, Manote Sutheerawattananonda, Nanteetip Limpeanchob

    Мақола20163 иқтибос
    ABI

  11. Structure–activity studies of protease activating, lipase inhibiting, bile acid binding and cholesterol-lowering effects of pre-screened cumin seed bioactive peptides

    Hwee-Leng Siow, Sy Bing Choi, Chee‐Yuen Gan

    Мақола20163 иқтибос
    ABI

  12. The Global Burden of Cardiovascular Diseases and Risk Factors

    George A. Mensah, Gregory A. Roth, Valentı́n Fuster

    Таҳририят мақоласи20193 иқтибос
    ABI

  13. Inhibition of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase enzyme by dipeptides identified in dry-cured ham

    Alejandro Heres, Leticia Mora, Fidel Toldrá

    Мақола20213 иқтибос
    ABI

  14. Design of competitive inhibitory peptides for HMG-CoA reductase and modeling structural preference for short linear peptides

    Valeriy V. Pak, Olim K. Khojimatov, Aleksandr V. Pak +1

    МақолаComputational Drug Discovery MethodsJournal of Molecular Structure20223 иқтибос
    ABI

  15. Evaluation of the hydrophobic parameters of the amino acid side chains of peptides and their application in QSAR and conformational studies

    Tomoko Sotomatsu-Niwa, Akio Ogino

    Мақола19972 иқтибос
    ABI

  16. Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016)

    G.B. John Mancini, Steven K. Baker, Jean Bergeron +9

    Шарҳ мақола20162 иқтибос
    ABI

  17. Structure-function properties of hypolipidemic peptides

    Satoshi Nagaoka

    Шарҳ мақола20182 иқтибос
    ABI

  18. Behavior of three hypocholesterolemic peptides from soy protein in an intestinal model based on differentiated Caco-2 cell

    Gilda Aiello, Simonetta Ferruzza, Giulia Ranaldi +4

    Мақола20182 иқтибос
    ABI

  19. Effects of products designed to modulate the gut microbiota on hyperlipidaemia

    Xilong Deng, Jie Ma, Meiting Song +4

    Шарҳ мақола20182 иқтибос
    ABI

  20. Statistical Methods for Research Workers.

    F. J. Anscombe, Ronald Aylmer Fisher

    Мақола19552 иқтибос
    ABI

  21. Statin Intolerance

    Zahid Ahmad

    Шарҳ мақола20142 иқтибос
    ABI

  22. Design of Tetrapeptides as a Competitive Inhibitor for HMG-CoA Reductase and Modeling Recognized Sequence as a β-Turn Structure

    Valeriy V. Pak, Olim K. Khojimatov, Aleksandr V. Pak +2

    МақолаRNA and protein synthesis mechanismsInternational Journal of Peptide Research and Therapeutics20222 иқтибос
    ABI

  23. The Global Burden of Disease Study at 30 years

    Christopher J L Murray

    Шарҳ мақола20222 иқтибос
    ABI

  24. Сарлавҳасиз

    Бошқа2 иқтибос
    ABI

  25. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI